- [GERP] 유전자편집·제어·복원기반기술개발사업 성과 누계 2025-07-22
- [논문] Development of melittin-conjugated lipid nanoparticle (LNP-MEL) for mRNA-based respiratory syncytial virus (RSV) vaccination 2025-07-22
- [논문] Advances in Therapeutic Applications of CRISPR Genome Editing for Spinal Pain Management 2025-07-22
- [논문] Functional assessment of all ATM SNVs using prime editing and deep learning 2025-07-22
- [논문] A rational engineering strategy for structural dynamics modulation enables target specificity enhancement of the Cas9 nuclease 2025-07-22
- [논문] Programmable RNA acetylation with CRISPR-Cas13 2025-07-22
- [논문] Evaluating the Therapeutic Potential of Superoxide Dismutase in a Rat Model of Wet Age-Related Macular Degeneration 2025-07-22
- [논문] Intravitreal adenine base editing of RS1 improves vision in a preclinical mouse model of retinoschisis 2025-07-21
- [Market] 미국에서 가장 비싼 10개 유전자치료제 2025-09-11
- [R&D] A general genome editing strategy using CRISPR lipid nanoparticle spherical nucleic acids 2025-09-11
- [R&D] 백신 조력자에서 세균 저격수로…지질나노입자의 반전 활약 2025-09-11
- [R&D] Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells 2025-09-04
- [R&D] Precise progerin targeting using RfxCas13d: A therapeutic avenue for Hutchinson-Gilford progeria syndrome 2025-09-04
- [R&D] 뇌신경 희귀 유전질환, 차세대 유전자가위로 '정밀 치료’ 2025-07-29
- [R&D] Precise progerin targeting using RfxCas13d: A therapeutic avenue for Hutchinson-Gilford progeria syndrome 2025-07-29
- [Policy] KBCH 보고서 - 유전자가위 주요 뉴스 2025-07-07
- 2025년 유전자편집제어복원기반기술개발사업 연구자 워크숍 개최 안내 2025-06-25
- 2025 IBS-GERP 공동 성과교류회 개최 안내 2025-02-14
- 2024 성과교류회 개최 안내 2024-08-13
- 2024 연구자 워크숍 성료 2024-07-01